Legal Representation
Attorney
Karl M. Zielaznicki
USPTO Deadlines
Next Deadline
17 days remaining
Notice of Publication
Due Date
August 07, 2025
Extension Available
Until September 07, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
21 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jul 8, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jul 8, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jul 2, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Jun 4, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
May 29, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
May 29, 2025 | ALIE | A | ASSIGNED TO LIE | Loading... |
May 29, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
May 16, 2025 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
May 13, 2025 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
May 13, 2025 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
May 13, 2025 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
May 13, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Feb 4, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Feb 4, 2025 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
Feb 4, 2025 | TAEA | I | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | Loading... |
Jan 27, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Jan 27, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Jan 27, 2025 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | Loading... |
Jan 27, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Nov 22, 2024 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
Nov 22, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of autoimmune disorders
Classification
International Classes
005